WO1998024412A3 - Compounds useful against diseases of the colon and methods for orally administering same - Google Patents
Compounds useful against diseases of the colon and methods for orally administering same Download PDFInfo
- Publication number
- WO1998024412A3 WO1998024412A3 PCT/US1997/022352 US9722352W WO9824412A3 WO 1998024412 A3 WO1998024412 A3 WO 1998024412A3 US 9722352 W US9722352 W US 9722352W WO 9824412 A3 WO9824412 A3 WO 9824412A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- colon
- methods
- compounds useful
- orally administering
- against diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
This invention is an enteric-coated granular formulation capable of targeting or persisting in the colonic region and a method for using the formulation to treat disorders of the colon wall.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3323596P | 1996-12-05 | 1996-12-05 | |
US60/033,235 | 1996-12-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1998024412A2 WO1998024412A2 (en) | 1998-06-11 |
WO1998024412A3 true WO1998024412A3 (en) | 1998-11-26 |
Family
ID=21869269
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1997/022352 WO1998024412A2 (en) | 1996-12-05 | 1997-12-03 | Compounds useful against diseases of the colon and methods for orally administering same |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO1998024412A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU766293B2 (en) * | 1998-11-27 | 2003-10-16 | Kanji Takada | An oral formulation for gastrointestinal drug delivery |
EP1284137B1 (en) * | 2000-05-26 | 2010-12-01 | TAKADA, Kanji | Nonoral preparation having three-layer structure |
DE10120092B4 (en) * | 2001-04-25 | 2008-03-20 | Lts Lohmann Therapie-Systeme Ag | Gastro-resistant device for the release of mucoadhesive active substance carriers and method for the production of the enteric device |
CN102813654A (en) * | 2002-04-05 | 2012-12-12 | 欧洲凯尔蒂克公司 | Matrix for sustained, invariant and independent release of active compounds |
CN108066296B (en) * | 2016-11-11 | 2020-11-17 | 南京益恒寿生命科技有限公司 | Colon targeting composition containing biological active components and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0077956A1 (en) * | 1981-10-15 | 1983-05-04 | Tanabe Seiyaku Co., Ltd. | Enteric microcapsules and process for the preparation thereof |
EP0250374A1 (en) * | 1986-06-17 | 1987-12-23 | RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.a. | Therapeutic system for controlled release of drugs |
WO1996029058A1 (en) * | 1995-03-21 | 1996-09-26 | Orion-Yhtymä Oy | Peroral composition for controlled release in the lower gastrointestinal tract |
-
1997
- 1997-12-03 WO PCT/US1997/022352 patent/WO1998024412A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0077956A1 (en) * | 1981-10-15 | 1983-05-04 | Tanabe Seiyaku Co., Ltd. | Enteric microcapsules and process for the preparation thereof |
EP0250374A1 (en) * | 1986-06-17 | 1987-12-23 | RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.a. | Therapeutic system for controlled release of drugs |
WO1996029058A1 (en) * | 1995-03-21 | 1996-09-26 | Orion-Yhtymä Oy | Peroral composition for controlled release in the lower gastrointestinal tract |
Also Published As
Publication number | Publication date |
---|---|
WO1998024412A2 (en) | 1998-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL121170A0 (en) | Compositions for the treatment of dermatological disorders | |
NL1003813A1 (en) | Device for the treatment of airway obstructions. | |
AU6124996A (en) | Certain arylsulfonamido-substituted hydroxamic acids for the treatment of certain tumors | |
NL300201I1 (en) | Compositions and formulations for producing analgesia and for inhibiting the progression of neuropathic pain. | |
AU7445594A (en) | Orally administrable opiod formulations having extended duration of effect | |
AU4010395A (en) | Compositions for increased bioavailability of orally delivered therapeutic agents | |
AU3153097A (en) | Pharmaceutical for treatment of neurological and neuropsychiatric disorders | |
AUPN737395A0 (en) | Process and apparatus for the manufacture of emulsion explosive compositions | |
WO2000040226A3 (en) | Method of treating sexual disturbances | |
AU6094996A (en) | Diphosphonate derivatives of therapeutic agents | |
ZA969001B (en) | Method compositions and kits for increasing the oral bioavailability of pharmaceutical agents | |
EP0690673A4 (en) | Systemic gene treatment of connective tissue diseases | |
IL117957A0 (en) | Pharmaceutical compositions for the treatment of impotence | |
MX9709238A (en) | Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders. | |
HUP9803018A3 (en) | Use of cyclooxygenase-2 inhibitors for producing pharmaceutical compositions suitable for the treatment and prevention of tumors, tumor-veloted disorders and cachexia | |
PL327628A1 (en) | Method of fighting against the expression of gene cd 44 for therapeutic purposes | |
AU3628395A (en) | Benz{g}indazolyl derivatives for the treatment of inflaminflammation | |
AU6858996A (en) | Pharmaceutical compositions for the treatment of infectious diseases | |
ZA968990B (en) | Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases. | |
WO1998024412A3 (en) | Compounds useful against diseases of the colon and methods for orally administering same | |
AU5800896A (en) | Non-steroidal anti-inflammatory drugs for the cyto-protection of the trabecular meshwork | |
AU5053296A (en) | Pharmaceutical agents for the treatment of Alzheimer's disease | |
CA2135709A1 (en) | Melatonin derivatives for use in treating sleep disorders | |
AU1104392A (en) | Method for the treatment of hepatic failure and disease | |
IL121096A0 (en) | Pharmaceutical compositions for the treatment of liver disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): CA JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): CA JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
122 | Ep: pct application non-entry in european phase |